Search Results Within Category "Digestive Systems & Liver Disease"

Here are the studies that match your search criteria. If you are interested in participating, please reach out to the contact listed for the study. If no contact is listed, contact us and we'll help you find the right person.

Search all categories
1results

A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3)

clinicaltrials@northshore.org

ALL
18 years to 80 years old
PHASE3
This study is NOT accepting healthy volunteers
NCT03519945
Show full eligibility criteria
Hide eligibility criteria
* Inclusion Criteria * Participants from Study AMAC (NCT02589665) or AMBG (NCT03524092) who have had at least one study drug administration and have not had early termination of study drug. * Female participants must agree to contraception requirements. * Exclusion Criteria * Participants must not have developed a new condition, including cancer in the originator study. * Participants must not have any important infections including, but not limited to, hepatitis B, hepatitis C, HIV/AIDS, and active tuberculosis (TB) during either originator study * Participants may not have received surgery for UC in the originator study or are likely to require surgery for treatment of UC during the study. * Participants must not have developed adenomatous polyps during the originator study that have not been removed prior to the start of this study.
DRUG: Mirikizumab
Ulcerative Colitis
Inflammatory Bowel Disease
I'm interested